Stroke
Conditions
Interventions
It will be a randomized controlled trial. Patients with clinical diagnosis of stroke and sequelae of neuromotor dysfunction, Health center users, patient registration centers and stroke support groups
(II) be between 30 and 70 years old
(III) agree and sign the voluntary participation consent form
(IV) time of injury greater than six months
(V) sequel to neuromotor dysfunction caused by stroke and (VI) earn more than 18 Mini-Mental Test points.
Exclusion criteria for patients in research include: (I) diagnosis of neurological or cardiova
(II) severe neuropsychological insufficiency (global aphasia, severe attention deficit or neglect), patient should follow instructions, understand how tasks performed, reduce differences in end result
Other
Q65.060
H02.010.625
Sponsors
Universidade Estadual de Maringa
Universidade Estadual de Maringa
Eligibility
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for research patients will be: (I) clinical diagnosis of stroke; (II) be between 30 and 70 years old; (III) agree and sign the voluntary participation consent form; (IV) time of injury greater than six months; (V) sequelae of neuromotor dysfunction resulting from stroke and (VI) earn over 18 Mini-Mental Test points.
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients under study will be: (I) diagnosis of neurological or cardiovascular instability, exercise contraindication (uncontrolled hypertension); (II) severe neuropsychological insufficiency (global aphasia, severe attention deficit or neglect), the patient should be able to follow instructions, understand the tasks performed, minimize differences in the final outcome due to lack of understanding of the tasks requested and performed, (III) impairment of the upper limb that prevents the performance of tasks and (IV) 18 points or less in the Mini-Mental Test.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To detect differences and changes in upper limb motor function in stroke patients after an 8-week neurofunctional rehabilitation program using subjective scales and kinematic analysis. Subjective assessment tools: (I) Fugl-Meyer Upper Limb Motor Scale and Wolf Motor Function Test to assess upper limb motor impairment, (II) Ashworth Modified Scale to classify muscle endurance passive movement and (III) The stroke-specific quality of life scale, SS-QOL, will be applied. The objective evaluation instruments: (I) The Vicon Motion System and the Skill Spector software. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the results collected on the motor function of the upper limbs of the subjective scales and the kinematic analysis of stroke patients after a neurofunctional rehabilitation program. Subjective assessment tools: (I) Fugl-Meyer Upper Limb Motor Scale and Wolf Motor Function Test to assess upper limb motor impairment, (II) Ashworth Modified Scale to classify muscle endurance passive movement and (III) The stroke-specific quality of life scale, SS-QOL, will be applied. The objective evaluation instruments: (I) The Vicon Motion System and the Skill Spector software. For three-dimensional kinematic data, the volunteer will perform the movements for each upper limb three times, following a simple verbal command: drink water and turn on / off the switch, which will be collected: (I) Displacement - range of motion of the analyzed joints, intra-articular linear relationship (shoulder and elbow, shoulder and hand, elbow and hand) and the proportion of the ideal trajectory of the hand and the actual trajectory of the hand. (II) Time - reaction time, total movement time and time of each movement phase. (III) Speed ??- average speed of total movement, average speed of each movement phase, maximum speed of total movement, and maximum speed of each movement phase. (IV) Smoothness - ratio between average speed and maximum speed, and peak speed range numbers. | — |
Countries
Brazil
Contacts
Public ContactFellipe Lima
Universidade Estadual de Maringa
Outcome results
None listed